Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,14,0.72 [0.52-0.99],0.0446373313879929
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,14,0.98 [0.91-1.06],0.595749088362131
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,14,1.94 [0.88-4.29],0.102415409596224
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,14,1.03 [0.91-1.17],0.631649094152792
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,14,1.03 [0.29-3.63],0.960957894811933
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,14,0.95 [0.85-1.05],0.292175650757097
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,14,1.02 [0.67-1.56],0.920837576339879
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,14,0.91 [0.76-1.09],0.3077861107124
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,14,0.93 [0.81-1.07],0.307993508432253
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,14,0.87 [0.77-0.98],0.0185699884895405
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",Inverse variance weighted,14,1.25 [0.94-1.66],0.132022972283401
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,14,0.93 [0.81-1.06],0.247969279716797
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,14,0.91 [0.84-1.00],0.0475580431703929
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,14,0.94 [0.83-1.06],0.337291665125345
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,14,0.93 [0.85-1.00],0.0657012509033471
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,14,0.92 [0.86-0.98],0.0077357176938604
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,14,0.99 [0.89-1.11],0.911551230985715
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,14,1.11 [0.87-1.42],0.39984427267732
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,14,0.93 [0.85-1.03],0.178823171609146
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,14,0.94 [0.86-1.03],0.184448822867598
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",Inverse variance weighted,14,0.96 [0.88-1.05],0.34426219079679
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,Inverse variance weighted,14,1.03 [0.93-1.15],0.535337808992077
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,14,1.02 [0.93-1.13],0.624344599887055
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,14,0.91 [0.83-1.00],0.0605806564638705
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,14,0.96 [0.87-1.07],0.474212312359462
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,14,0.93 [0.72-1.20],0.584369430151454
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,14,0.93 [0.83-1.04],0.181065087925098
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,14,1.01 [0.88-1.15],0.927663897657396
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,14,0.96 [0.88-1.05],0.386165208985179
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,14,1.00 [0.92-1.09],0.932311236256883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,14,0.95 [0.78-1.15],0.578973368849958
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,14,0.96 [0.91-1.01],0.130777220252028
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,14,0.96 [0.91-1.02],0.229191971788979
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,14,1.58 [0.59-4.29],0.364664809463575
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,14,0.79 [0.53-1.18],0.246345338680781
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,14,0.96 [0.89-1.04],0.310288439775883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,14,0.95 [0.86-1.06],0.370566266497929
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,14,0.97 [0.86-1.09],0.586419177748075
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,14,0.65 [0.49-0.86],0.0029981977406305
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,14,0.95 [0.82-1.11],0.522523748410568
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,14,0.86 [0.54-1.38],0.537542190805648
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,14,0.93 [0.86-1.02],0.111310050319018
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,Inverse variance weighted,14,0.96 [0.85-1.08],0.472955892654762
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,14,1.12 [0.92-1.37],0.244620471902243
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,14,1.06 [0.79-1.40],0.708408307936325
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,14,0.91 [0.75-1.09],0.30457379271503
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,14,0.97 [0.90-1.04],0.381162425896883
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,14,0.96 [0.91-1.02],0.191547840063093
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,14,0.95 [0.90-1.00],0.0733122558158897
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,14,0.96 [0.86-1.07],0.446576549923304
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,14,1.00 [0.90-1.11],0.97710666328271
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,14,0.99 [0.81-1.20],0.900124561837524
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,14,1.05 [0.93-1.18],0.413967335213805
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,14,0.95 [0.90-1.01],0.0822630606452904
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,14,0.91 [0.78-1.07],0.247220841047653
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,14,0.97 [0.91-1.04],0.452355205150901
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,14,1.15 [1.00-1.33],0.0504830750667901
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,14,0.96 [0.91-1.01],0.0914563279245244
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,14,0.88 [0.78-1.00],0.0496860129970448
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,14,0.94 [0.86-1.03],0.191426049350332
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,14,1.00 [0.94-1.06],0.969127331460998
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,14,1.03 [0.94-1.12],0.593987487280218
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,14,0.94 [0.89-0.99],0.0175526975917571
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,14,0.99 [0.90-1.08],0.798596724532873
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,14,1.04 [0.88-1.23],0.649008776718479
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,14,0.99 [0.94-1.05],0.724534369768479
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,14,0.97 [0.89-1.06],0.531726363288718
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,14,1.01 [0.85-1.19],0.914671124013504
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,14,1.08 [0.94-1.23],0.301232952429748
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,14,0.92 [0.74-1.15],0.482210391382749
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,14,1.02 [0.95-1.11],0.56955036295291
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,14,0.96 [0.74-1.23],0.723549431246674
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,Inverse variance weighted,14,1.04 [0.97-1.11],0.276511875053301
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,Inverse variance weighted,14,0.94 [0.78-1.14],0.525573569237582
TNFSF13,Tumor necrosis factor ligand superfamily member 13,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,Inverse variance weighted,14,0.94 [0.87-1.02],0.128197432266589
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,14,1.08 [0.83-1.41],0.576063060776131
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,14,1.02 [0.85-1.22],0.868804232190428
TNFSF13,Tumor necrosis factor ligand superfamily member 13,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,14,0.74 [0.57-0.98],0.0334193776537565
